Call for Abstract

6th European Conference on Predictive , Preventive and Personalized Medicine & Molecular Diagnostics, will be organized around the theme “Unleashing the novel approaches in advancing Personalized Medicine”

Euro Personalized Medicine 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Personalized Medicine 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

In personalized medicine molecular diagnostics is used for analysing of biological markers and also analysing by applying molecular biology to medical testing .This technique is used to diagnose and monitor disease,detect risk in individual patients .DNA sequencing is the process of determining the precise order of nucleotides within a DNA  molecule .SNP genotyping is the measurement of genetic variations of single nucleotide polymorphism (SNPs) . which is the measurement of more general genetic variation.Gene expression  profiling is used for the measurement of  the activity of thousands of genes at once.

  • Track 1-1Cancer Diagnostics
  • Track 1-2Molecular pathology
  • Track 1-3DNA sequencing
  • Track 1-4Gene expression profiling
  • Track 1-5Precise Molecular Diagnostics
  • Track 1-6Plant Breeding

In personalized medicine  biomarkers and  biological marker  generally refers to a measurable indicator  of some biological state or condition. This word  refer to a substance the presence of which indicates the existence of a living organism. Biochemical biomarkers are often used in clinical trials, Biomarkers used for personalized medicine are typically categorized as either prognostic or predictive .In  , a biomarkers is a molecule that allows the detection and isolation of a particular cell type .  A biomarker indicates a change in  state of a protein that correlates with the risk or progression of a disease . Biomarkers are useful in a number of ways, including measuring the progress of disease. Biomarkers also used in  early diagnosis, disease prevention, drug target identification, drug response etc.

  • Track 2-1Molecular biomarkers
  • Track 2-2DNA biomarkers
  • Track 2-3Predictive biomarkers
  • Track 2-4Bioinformatics in personalized medicine
  • Track 2-5Cancer Biomarkers

In personalized medicine pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect the drug responses, like therapeutic effect as well as adverse effect. Inter- and intra-individual variation in gene expression and  its function.In oncology, pharmacogenetics refers to germline mutations and pharmacogenomics is study the somatic mutations in tumoral DNA leading to alteration in drug response.

  • Track 3-1Pharmacogenetics and drug development
  • Track 3-2Drugs metabolized by CYP2C19
  • Track 3-3Careers in pharmacogenomics
  • Track 3-4Pharmacogenetics and adverse drug reactions
  • Track 3-5Next Generation Sequencing

Pharmacogenomics is the study of  the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response, drug absorption distribution, metabolism, and elimination ,as well as drug receptor target effects . Pharmacogenomics isoften used interchangeably with pharmacogenetics. Pharmacogenomics is used for the detection of   the individual genetic variation with drug responses pharmacogenetics focuses on single drug-gene interactions, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.

 

  • Track 4-1Genetic testing for drug metabolism
  • Track 4-2Genetic express on clinical studies
  • Track 4-3Psychiatric Genetic Testing
  • Track 4-4Future prospects of pharmacogenomics
  • Track 4-5Microbial Genomics

The proteome is the entire set of proteins it is expressed by genome , cell, tissue, or organism at a certain time. More specifically, it is a combined of proteins and genomes . Proteomics is the study of the proteome. A cellular  proteome is the collection of proteins present in a particular cell type and it exposure to harmone stimulation . It can also be useful to consider an organisms complete proteome, which can be conceptualized as the complete set of proteins from all of the various cellular proteomes. Proteome used to refer to the collection of proteins in certain sub-cellular biological systems .

  • Track 5-1DNA and RNA microarrays
  • Track 5-2Proteomics in personalized medicine
  • Track 5-3Nanoproteomics and genomics

Metabolomics is defined as the chemical processes involving of  metabolites. Metabolomics is the  study of the unique chemical fingerprints. The metabolome refers to the collection of all metabolites in a biological cell, tissue, organ or organism. mRNA gene expression data and proteomic analyses reveals the set of gene products in the cell. One of the challenges of system biology and functional genomics  is to integrate proteomic ,transcriptomic, and metabolomic information to provide a cellular biology.

  • Track 6-1DNA test for drug metabolism
  • Track 6-2Personalized nutrition
  • Track 6-3Metabolic phenotyping
  • Track 6-4Blood transcriptomics

Biological therapy refers to the use of medication , specifically target an immune or genetic mediator of disease. Even for diseases of unknown cause of  molecules that are involved in the disease process have been identified, and can be targeted for biological therapy. which are mainly cytokines , are directly involved in the immune system .Biological therapy used for the management of cancer , autoimmune disease, and diseases of unknown cause that result in symptoms due to immune related mechanisms.

  • Track 7-1Recombinant human proteins
  • Track 7-2Personalized therapy in lung cancer
  • Track 7-3Stem cell in personalized gene therapy
  • Track 7-4Treating breast cancer 21st century

Cancer is cured by surgery ,chemotherapy , radiation therapy , hormonal therapy  and targeted therapy including immuno therapy such as monoclonal antibody therapy. The choice of therapy depends upon the location ,tumor and stage of disease as well as the general state of the patient.

  • Track 8-1Personalized cancer vaccines
  • Track 8-2Molecular imaging in personalized medicine
  • Track 8-3Immunotherapy of cancer
  • Track 8-4Target based personalized therapy

Infection is invasion of an organisms , body tissues by disease causing agents their multiplication and the reaction of  host tissues to these organisms and they produced toxins . Infectious disease also known as transmissible disease and  communicable disease, is illness resulting from an infection.

  • Track 9-1Bacterial infections
  • Track 9-2Infection of Tuberculosis
  • Track 9-3 Fungal infections
  • Track 9-4Viral infections
  • Track 9-5Diagnostic assays

A neurological disorder is any disorder r of the body nervous system. Structural, biochemical or electrical abnormalities of brain, spinal cord or other nerves can result in a range of symptoms. The symptoms include paralysis, muscle weakness , loss of sensation,seizures confusion pain and altered levels of consciousness.They may be assessed by neurological examination, studied and treated within the specialities of nuerology and clinical neuropsychology.

  • Track 10-1Neurological disoders
  • Track 10-2Personalized management of epilepsy
  • Track 10-3 Treatment of traumatic brain injury
  • Track 10-4Neurometabolomics

Mental disorders are  psychological condition primarily by sufficient disorganization of  personality, mind, emotions to seriously impair the normal psychological condition. Mental disorders occasionally consist a combination of affective behavioural cognitive perceptual components. The acknowledgement of mental health conditions has changed over time and across cultures, and still observed variations in the definition,classification,and treatment of mental disorders.

  • Track 11-1Psychopharmacogenetics/psychopharmacodynamics
  • Track 11-2Personalized antipsychotic therapy
  • Track 11-3 Prospects in personalized psychiatry
  • Track 11-4Personalized antipsychotic therapy

Cardiovascular disorders is require an organized interpretation of variations in DNA and mRNA as well as proteins. The advance biotechnology is being applied to improve the diagnosis and treatment of cardiovascular disorders. A five-step strategy can be followed to identify genes and gene products involved in differential responses to cardiovascular drugs.

  • Track 12-1Biomarkers in CV disoders
  • Track 12-2Thrombotic disorders
  • Track 12-3Infectious disease of interstitial
  • Track 12-4 Personalized management of hypertension
  • Track 12-5Chronic myocardial ischemia

Chronic obstructive pulmonarydisease is a type of  obstructive lung disease characterized. The main symptoms includes a breath and cough  with suptum production.COPD typically worsens over time . Eventually walking up stairs or carrying things will be difficult. Tobacco smoking is the most common with a number of other factors such as air pollution and genetics.

  • Track 13-1Personalized therapy of asthma
  • Track 13-2Lebrikizumab for personalized treatment of asthma
  • Track 13-3Therapy of chronic pulmonary disease
  • Track 13-4 Interstitial lung disease

Genetic disorders may or may not be heritable from the parents genes. In non-heritable genetic disorders, defects may be caused by new mutations  and changes to the DNA. In such cases, the defect will only be heritable if it occurs in the germ line .Such as some forms of cancer, may be caused by an inherited genetic condition in some people by new mutations in other people, and mainly by environmental causes in other people. Whether, when and to what extent a person with the genetic defect abnormality will actually suffer from the disease is almost always affected by the environmental factors and events in the persons development.

  • Track 14-1Biomarkers in genetic disorders
  • Track 14-2Molecular diagnostics in genetic disorders
  • Track 14-3Personalized treatment of cystic fibrosis
  • Track 14-4Personalized medicine in Era of genomics

Autoimmune diseases is damage a pathologic state arising from an abnormal immune response of the body against substances and tissues are normally present in the body. Autoimmunity is the presence of self-reactive immune response. (e.g., auto-antibodies and  self-reactive T-cells) with or without damage or pathology resulting from it.

  • Track 15-1Immune biomarkers
  • Track 15-2Personalized vaccinology
  • Track 15-3Personalized organ transplantation
  • Track 15-4Molecular neurobiology of depression

Personalized medicine is a Medical Practice that separates patients into different groups with medical decisions, practices, interventions and  products being tailored to the individual patient based on their predicted response or risk of disease. The words of  personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably.

  • Track 16-1Personalized medicine for diabetes
  • Track 16-2Personalized medicine for skin disorders
  • Track 16-3Personalized medicine for GI disorders
  • Track 16-4Personalized medicine for renal disease
  • Track 16-5Personalized preventive medicine

Personalized medicine is a Medical Practice that separates patients into different groups with medical decisions, practices, interventions and  products being tailored to the individual patient based on their predicted response or risk of disease. The words of  personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably.

  • Track 17-1Personalized medicine coalition
  • Track 17-2Personalized drug discovery
  • Track 17-3Personalized prognosis of disease
  • Track 17-4Drug delivery in personalized medicine

Medical ethics is a system of moral principles that apply values and judgments to medical practice. As a scholarly discipline, medical ethics encompasse its application in clinical settings as well as work on its history, philosophy, and sociology.

  • Track 18-1Ethical aspects of genetic information
  • Track 18-2Genotype in clinical trails
  • Track 18-3Gene patents and Personalized medicine

 Health economics is a study of economics concerned with issues related to efficiency, effectiveness, value , behavior in the consumption of  healthcare. In broad terms health economists study the functioning of healthcare systems and health-affecting behaviors such as smoking.Health economists evaluate multiple types of financial information costs, charges and expenditures.

  • Track 19-1Genetic testing for healthcare
  • Track 19-2Economics for Personalized medicine
  • Track 19-3Lowering the high costs of cancer chemotherapy
  • Track 19-4Translational science in Personalized medicine

The FDA is  already started to take initiatives to integrate personalized medicine into their regulatory policies.They developed a report in October 2013 entitled Paving the Way for Personalized Medicine FDAs role in a New Era of Medical Product Development in which they outlined steps they would have to take to integrate genetic and biomarker information for clinical use and drug development. They determined that they would have to develop specific regulatory science standards, research methods, reference material and other tools in order to incorporate personalized medicine into their current regulatory practices. For example, they are working on a genomic reference library for regulatory agencies to compare and test the validity of different sequencing platforms in an effort to uphold reliability.

  • Track 20-1FDA and Personalized medicine
  • Track 20-2Regulatory aspects of pharmacogenetics
  • Track 20-3FDA and predictive medicine
  • Track 20-4FDA and validation of biomarkers

Personalized medicine is a Medical Practice that separates patients into different groups with medical decisions, practices, interventions and  products being tailored to the individual patient based on their predicted response or risk of disease. The words of  personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably.

  • Track 21-1Opportunities for Personalized medicine
  • Track 21-2Future of Personalized medicine
  • Track 21-3Testing for healthcare

National Science Foundation (NSF) announces its intention to continue to support plant genome research through the Plant Genome Research Program (PGRP). Plant Genomics Research Program (PGRP) awards from the National Science Foundation (NSF) that NSF offers supplements to support research collaboration with scientist sin developing countries. The intent of Developing Country Collaborations in Plant Genome Research (DCC-PGR) awards is to support collaborative research linking U.S. researchers with partners from developing countries to solve problems of mutual interest in agriculture, energy and the environment, while placing U.S. and international researchers at the center of a global network of scientific excellence.

  • Track 22-1Plant Breeding
  • Track 22-2Transgenic Plants
  • Track 22-3Plant Genomics in World Economy
  • Track 22-4Rice Genome
  • Track 22-5Plant Genomics Applications
  • Track 22-6Bioinformatics
  • Track 22-7Single cell Genomics